Diagnosis, treatment, and nursing care of patients with chronic leukemia.
OBJECTIVE
To provide an update on the impact of new information about the molecular biology of chronic leukemia and new treatment modalities available to patients.


METHODS
Published articles, books, and research studies.


CONCLUSIONS
There has been significant progress in the diagnosis and management of chronic myeloid and chronic lymphocytic leukemia. New therapies provide more options for patients and longer treatment periods.


CONCLUSIONS
With increasing treatment options and longer survival, patients with chronic myelogenous or chronic lymphocytic leukemia need increased education, support, and assistance with symptom management. Nurses caring for these patients must remain knowledgeable about new treatments and their management.
Breed
Cheryl D
CD
Department of Hematology/Oncology, University of California San Francisco, 400 Parnassus Ave, Box 0324, Room A 502, San Francisco, CA 94143-0324, USA.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000451:nursing / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000451:nursing / Q000628:therapy; D024802:Nurse's Role; D009723:Nurse-Patient Relations; D009730:Nursing Assessment / Q000379:methods; D009859:Oncology Nursing / Q000193:education / Q000379:methods* / Q000592:standards*; D033581:Stem Cell Transplantation / Q000379:methods; D014481:United States
D000970:Antineoplastic Agents